EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C4H3F7O |
| Net Charge | 0 |
| Average Mass | 200.053 |
| Monoisotopic Mass | 200.00721 |
| SMILES | FCOC(C(F)(F)F)C(F)(F)F |
| InChI | InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2 |
| InChIKey | DFEYYRMXOJXZRJ-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | anti-obesity agent Any substance which is used to reduce or control weight. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | central nervous system depressant A loosely defined group of drugs that tend to reduce the activity of the central nervous system. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. renoprotective agent Any compound that is able to prevent damage to the kidneys. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. anti-inflammatory agent Any compound that has anti-inflammatory effects. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. antidote Any protective agent counteracting or neutralizing the action of poisons. platelet aggregation inhibitor A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| sevoflurane (CHEBI:9130) has functional parent 2-methoxypropane (CHEBI:53505) |
| sevoflurane (CHEBI:9130) has role analgesic (CHEBI:35480) |
| sevoflurane (CHEBI:9130) has role anti-inflammatory agent (CHEBI:67079) |
| sevoflurane (CHEBI:9130) has role anti-obesity agent (CHEBI:74518) |
| sevoflurane (CHEBI:9130) has role antidote (CHEBI:50247) |
| sevoflurane (CHEBI:9130) has role antineoplastic agent (CHEBI:35610) |
| sevoflurane (CHEBI:9130) has role antiviral agent (CHEBI:22587) |
| sevoflurane (CHEBI:9130) has role anxiolytic drug (CHEBI:35474) |
| sevoflurane (CHEBI:9130) has role cardiovascular drug (CHEBI:35554) |
| sevoflurane (CHEBI:9130) has role central nervous system depressant (CHEBI:35488) |
| sevoflurane (CHEBI:9130) has role inhalation anaesthetic (CHEBI:38870) |
| sevoflurane (CHEBI:9130) has role neuroprotective agent (CHEBI:63726) |
| sevoflurane (CHEBI:9130) has role platelet aggregation inhibitor (CHEBI:50427) |
| sevoflurane (CHEBI:9130) has role renoprotective agent (CHEBI:231911) |
| sevoflurane (CHEBI:9130) is a ether (CHEBI:25698) |
| sevoflurane (CHEBI:9130) is a organofluorine compound (CHEBI:37143) |
| IUPAC Name |
|---|
| 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane |
| INNs | Source |
|---|---|
| Sevoflurane | ChemIDplus |
| Sevoflurano | ChemIDplus |
| Sevofluranum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane | ChemIDplus |
| MR-6S4 | ChEMBL |
| MR_6S4 | ChEMBL |
| MR6S4 | ChEMBL |
| NSC-760367 | ChEMBL |
| Sevocalm | ChEMBL |
| Brand Names | Source |
|---|---|
| Sevohale (previously known as sevocalm) | ChEMBL |
| Sojourn | ChEMBL |
| Ultane | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| Beilstein:2041023 | Beilstein |
| CAS:28523-86-6 | KEGG COMPOUND |
| CAS:28523-86-6 | KEGG DRUG |
| CAS:28523-86-6 | ChemIDplus |
| CAS:28523-86-6 | NIST Chemistry WebBook |
| CAS:28523-86-6 | DrugBank |
| Citations |
|---|